CAS 1225037-39-7

Fórmula: C17H20F3N7O2

InChI: InChI=1S/C17H20F3N7O2/c18-17(19,20)12-9-13(21)22-10-11(12)14-23-15(26-1-5-28-6-2-26)25-16(24-14)27-3-7-29-8-4-27/h9-10H,1-8H2,(H2,21,22)

Chave InChI: ADGGYDAFIHSYFI-UHFFFAOYSA-N

SMILES: C1COCCN1C2=NC(=NC(=N2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4

5-(4,6-Dimorpholino-1,3,5-Triazin-2-Yl)-4-(Trifluoromethyl)Pyridin-2-Amine

CAS: 1225037-39-7

5-(4,6-Dimorpholino-1,3,5-Triazin-2-Yl)-4-(Trifluoromethyl)Pyridin-2-Amine

Fórmula: C₁₇H₂₀F₃N₇O₂

Pureza: 98%

Peso molecular: 411.38

Ref: 54-PC108466

Bimiralisib

CAS: 1225037-39-7

Bimiralisib

Fórmula: C₁₇H₂₀F₃N₇O₂

Pureza: 98.5%

Peso molecular: 411.38

Ref: 54-BUP12380

5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine

CAS: 1225037-39-7

5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine

Fórmula: C₁₇H₂₀F₃N₇O₂

Pureza: 98%

Peso molecular: 411.38

Ref: IN-DG583924

Bimiralisib

CAS: 1225037-39-7

Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity.

Fórmula: C₁₇H₂₀F₃N₇O₂

Pureza: 97.58% - 98.92%

Cor e Forma: Solid

Peso molecular: 411.38

Ref: TM-T2265

Bimiralisib

Produto Controlado

CAS: 1225037-39-7

Fórmula: C₁₇H₂₀F₃N₇O₂

Cor e Forma: Neat

Peso molecular: 411.382

Ref: TR-B386840

5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine

CAS: 1225037-39-7

Fórmula: C₁₇H₂₀F₃N₇O₂

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 411.3816

Ref: IN-DA009CJM